| RS1555560140 |
G6PC1
|
Health Risk |
Likely pathogenic |
Glycogen storage disease due to glucose-6-phosphatase deficiency type IA, Glycogen storage disease due to glucose-6-phosphatase deficiency type IA |
| RS1555560149 |
G6PC1
|
Health Risk |
Likely pathogenic |
Glycogen storage disease due to glucose-6-phosphatase deficiency type IA, Glycogen storage disease due to glucose-6-phosphatase deficiency type IA |
| RS1555560185 |
G6PC1
|
Health Risk |
Likely pathogenic |
Glycogen storage disease due to glucose-6-phosphatase deficiency type IA, Glycogen storage disease due to glucose-6-phosphatase deficiency type IA |
| RS1555560204 |
G6PC1
|
Health Risk |
Pathogenic |
Glycogen storage disease due to glucose-6-phosphatase deficiency type IA, Glycogen storage disease due to glucose-6-phosphatase deficiency type IA |
| RS1555560637 |
CTNS
|
Health Risk |
Likely pathogenic |
Nephropathic cystinosis, Nephropathic cystinosis |
| RS1555561048 |
CTNS
|
Health Risk |
Likely pathogenic |
Nephropathic cystinosis, Ocular cystinosis |
| RS1555561049 |
CTNS
|
Health Risk |
Likely pathogenic |
Nephropathic cystinosis, Ocular cystinosis |
| RS1555561294 |
FANCA
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group A, Fanconi anemia |
| RS1555562364 |
STAT3
|
Health Risk |
Likely pathogenic |
STAT3 gain of function, Hyper-IgE recurrent infection syndrome 1 |
| RS1555562577 |
WDR81
|
Health Risk |
Likely pathogenic |
— |
| RS1555562830 |
CTNS
|
Health Risk |
Likely pathogenic |
Nephropathic cystinosis, Nephropathic cystinosis |
| RS1555563010 |
CTNS
|
Health Risk |
Likely pathogenic |
Nephropathic cystinosis, Nephropathic cystinosis |
| RS1555563441 |
CTNS
|
Health Risk |
Pathogenic |
— |
| RS1555563446 |
CTNS
|
Health Risk |
Pathogenic |
Nephropathic cystinosis, Ocular cystinosis |
| RS1555563521 |
CTNS
|
Health Risk |
Likely pathogenic |
Nephropathic cystinosis, Nephropathic cystinosis |
| RS1555563568 |
CTNS
|
Health Risk |
Likely pathogenic |
Nephropathic cystinosis, Nephropathic cystinosis |
| RS1555563658 |
CTNS
|
Health Risk |
Likely pathogenic |
Nephropathic cystinosis, Nephropathic cystinosis |
| RS1555563717 |
STAT3
|
Health Risk |
Pathogenic/Likely pathogenic |
Hyper-IgE recurrent infection syndrome 1, autosomal dominant |
| RS1555563725 |
NEK8
|
Health Risk |
Pathogenic |
— |
| RS1555563787 |
NEK8
|
Health Risk |
Pathogenic |
Renal-hepatic-pancreatic dysplasia 2, Renal-hepatic-pancreatic dysplasia 2 |
| RS1555563854 |
STAT3
|
Health Risk |
Pathogenic/Likely pathogenic |
STAT3 gain of function, Hyper-IgE recurrent infection syndrome 1 |
| RS1555563871 |
STAT3
|
Health Risk |
Pathogenic |
Hyper-IgE recurrent infection syndrome 1, autosomal dominant |
| RS1555563981 |
EFTUD2
|
Health Risk |
Pathogenic |
— |
| RS1555563982 |
CTNS
|
Health Risk |
Pathogenic |
Nephropathic cystinosis, Ocular cystinosis |
| RS1555563998 |
EFTUD2
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1555564006 |
EFTUD2
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1555564032 |
PMP22
|
Health Risk |
Likely pathogenic |
Charcot-Marie-Tooth disease, type IA |
| RS1555564040 |
PMP22
|
Health Risk |
Likely pathogenic |
Charcot-Marie-Tooth disease, type I |
| RS1555564050 |
PMP22
|
Health Risk |
Likely pathogenic |
— |
| RS1555564126 |
EFTUD2
|
Health Risk |
Likely pathogenic |
Mandibulofacial dysostosis-microcephaly syndrome, Mandibulofacial dysostosis-microcephaly syndrome |
| RS1555564134 |
NEK8
|
Health Risk |
Pathogenic |
Nephronophthisis 9, Nephronophthisis 9 |
| RS1555564175 |
EFTUD2
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1555564214 |
NEK8
|
Health Risk |
Likely pathogenic |
Nephronophthisis 9, Nephronophthisis 9 |
| RS1555564341 |
EFTUD2
|
Health Risk |
Pathogenic |
Mandibulofacial dysostosis-microcephaly syndrome, Mandibulofacial dysostosis-microcephaly syndrome |
| RS1555564436 |
FANCA
|
Health Risk |
Likely pathogenic |
Fanconi anemia complementation group A, Fanconi anemia |
| RS1555564451 |
FANCA
|
Health Risk |
Likely pathogenic |
Fanconi anemia complementation group A, Fanconi anemia complementation group A |
| RS1555564487 |
SYNE2
|
Health Risk |
Conflicting classifications of pathogenicity |
Emery-Dreifuss muscular dystrophy 5, autosomal dominant |
| RS1555564588 |
CTNS
|
Health Risk |
Likely pathogenic |
Nephropathic cystinosis, Ocular cystinosis |
| RS1555564600 |
CTNS
|
Health Risk |
Likely pathogenic |
Nephropathic cystinosis, Ocular cystinosis |
| RS1555564823 |
CTNS
|
Health Risk |
Likely pathogenic |
Nephropathic cystinosis, Nephropathic cystinosis |
| RS1555565043 |
RAI1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1555565108 |
RAI1
|
Health Risk |
Likely pathogenic |
— |
| RS1555565162 |
EFTUD2
|
Health Risk |
Pathogenic |
— |
| RS1555565170 |
RAI1
|
Health Risk |
Likely pathogenic |
— |
| RS1555565243 |
RAI1
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1555565276 |
PMP22
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease, type I |
| RS1555565283 |
PMP22
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease, type I |
| RS1555565426 |
RAI1
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1555565492 |
RAI1
|
Health Risk |
Pathogenic |
Smith-Magenis syndrome, Smith-Magenis syndrome |
| RS1555565533 |
RAI1
|
Health Risk |
Pathogenic |
— |
| RS1555565595 |
STAT3
|
Health Risk |
Likely pathogenic |
— |
| RS1555565674 |
RAI1
|
Health Risk |
Pathogenic |
— |
| RS1555565772 |
EFTUD2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1555565774 |
EFTUD2
|
Health Risk |
Pathogenic |
Mandibulofacial dysostosis-microcephaly syndrome, Mandibulofacial dysostosis-microcephaly syndrome |
| RS1555565807 |
EFTUD2
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1555566042 |
RAI1
|
Health Risk |
Pathogenic |
Smith-Magenis syndrome, Smith-Magenis syndrome |
| RS1555566124 |
RAI1
|
Health Risk |
Pathogenic |
— |
| RS1555566164 |
RAI1
|
Health Risk |
Likely pathogenic |
— |
| RS1555566286 |
RAI1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1555566545 |
FANCA
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia, Inborn genetic diseases |
| RS1555566820 |
STAT3
|
Health Risk |
Conflicting classifications of pathogenicity |
STAT3 gain of function, Hyper-IgE recurrent infection syndrome 1 |
| RS1555566945 |
STAT3
|
Health Risk |
Likely pathogenic |
STAT3 gain of function, Hyper-IgE recurrent infection syndrome 1 |
| RS1555566979 |
RAD51D
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS1555567076 |
RAD51D
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS1555567170 |
RAD51D
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Breast-ovarian cancer |
| RS1555567197 |
RAD51D
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS1555567202 |
RAD51D
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Breast-ovarian cancer |
| RS1555567496 |
RAD51D
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Breast-ovarian cancer |
| RS1555567529 |
RAD51D
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS1555567586 |
RAD51D
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1555567610 |
RAD51D
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Breast-ovarian cancer |
| RS1555567649 |
RAD51D
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Breast-ovarian cancer |
| RS1555568133 |
SGCA
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1555568139 |
TOP3A
|
Health Risk |
Pathogenic |
Microcephaly, growth restriction |
| RS1555568159 |
RAD51D
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Breast-ovarian cancer |
| RS1555568264 |
SGCA
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2D, Autosomal recessive limb-girdle muscular dystrophy type 2D |
| RS1555568293 |
RAD51D
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Breast-ovarian cancer |
| RS1555568296 |
RAD51D
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS1555568301 |
RAD51D
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS1555568318 |
SGCA
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2D, Autosomal recessive limb-girdle muscular dystrophy type 2D |
| RS1555568325 |
SGCA
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2D, Autosomal recessive limb-girdle muscular dystrophy type 2D |
| RS1555568335 |
SGCA
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2D, Autosomal recessive limb-girdle muscular dystrophy type 2D |
| RS1555568382 |
RAD51D
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS1555568383 |
SGCA
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2D, Autosomal recessive limb-girdle muscular dystrophy type 2D |
| RS1555568386 |
RAD51D
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Breast-ovarian cancer |
| RS1555568392 |
RAD51D
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Breast-ovarian cancer |
| RS1555568396 |
SGCA
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2D, Autosomal recessive limb-girdle muscular dystrophy type 2D |
| RS1555568466 |
RAD51D
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Breast-ovarian cancer |
| RS1555568469 |
RAD51D
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary breast ovarian cancer syndrome |
| RS1555568473 |
RAD51D
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS1555568475 |
PMP22
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease, type I |
| RS1555568514 |
RAD51D
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Breast-ovarian cancer |
| RS1555568518 |
SGCA
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2D, Autosomal recessive limb-girdle muscular dystrophy type 2D |
| RS1555568535 |
STAT3
|
Health Risk |
Conflicting classifications of pathogenicity |
STAT3 gain of function, Hyper-IgE recurrent infection syndrome 1 |
| RS1555568575 |
TEX14
|
Health Risk |
Pathogenic |
Spermatogenic failure 23, Spermatogenic failure 23 |
| RS1555568775 |
SGCA
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2D, Autosomal recessive limb-girdle muscular dystrophy type 2D |
| RS1555568876 |
SGCA
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2D, Autosomal recessive limb-girdle muscular dystrophy type 2D |
| RS1555568965 |
SGCA
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2D, Autosomal recessive limb-girdle muscular dystrophy type 2D |
| RS1555569127 |
EFTUD2
|
Health Risk |
Likely pathogenic |
— |
| RS1555569283 |
EFTUD2
|
Health Risk |
Pathogenic |
— |